Business

Vergence Naturals and Naturopathic Doctor and Nutraceutical Product Developer Brazos Minshew Launch Comfort

Vergence Naturals and Naturopathic Doctor and Nutraceutical Product Developer Brazos Minshew Launch Comfort.

articleAbattis Bioceuticals CorpDecember 18, 20184/company/abattis-bioceuticals-corp/news/vergence-naturals-and-naturopathic-doctor-and-nutraceutical-product-developer-brazos-minshew-launch-comfort
Vergence Naturals and Naturopathic Doctor and Nutraceutical Product Developer Brazos Minshew Launch Comfort

About this update from Abattis Bioceuticals Corp

[{"type":"text","content":"\n\n\n\nVergence Naturals and Naturopathic Doctor and Nutraceutical Product Developer Brazos Minshew Launch Comfort\n\n/* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n\n\n\n\n\n\nVergence Naturals and Naturopathic Doctor and Nutraceutical Product Developer Brazos Minshew Launch Comfort\nPR Newswire\nVANCOUVER, British Columbia, Dec. 18, 2018\n\n\n\nVANCOUVER, British Columbia, Dec. 18, 2018 /PRNewswire/ -- Abattis Bioceuticals Corp (the \"Company\" or \"Abattis\") (CSE:ATT) (OTC:ATTBF) is pleased to announce its first proprietary product, Comfort,  which has been produced through wholly owned subsidiary Vergence Naturals (\"Vergence\"). Abattis has teamed up with respected naturopathic doctor and nutraceuticals product developer Dr. Brazos Minshew to launch Comfort, a breakthrough nutraceutical combining traditional herbal remedies to safely and effectively address occasional pain. Released on Cyber Monday and set for introduction into the US and Canada in December 2018, the Comfort product is 100% owned by Vergence, and will be marketed under the newly-formed health and wellness brand. Comfort offers a unique combination of phytocannabinoids from non-cannabis sources to safely and effectively address occasional pain. Dr. Minshew currently serves as President of Abattis' Medical Advisory Board. \nFor thousands of years plants have been used in medicine to reduce occasional pain. For example, Aspirin is derived from White Willow Bark, and morphine is derived from plants in the poppy species. Following this trend, cannabinoids from marijuana have been used by progressive physicians to successfully treat pain. Scientists have identified cannabinoids in many non-cannabis plants, such as hops, turmeric and cocoa which yield full-functional health benefits. Comfort by Vergence (www.comfortbyvergence.com) uniquely blends five non-cannabis plants used to reduce occasional pain by interacting with cannabis receptors in the brain without any cannabis side effects.\nDr. Minshew and Abattis successfully combined five phytocannabinoids to create Comfort, including:\n- &#160...

More updates from Abattis Bioceuticals Corp